Dynorphin A increases substance P release from trigeminal primary afferent C-fibers

scientific article published in January 1999

Dynorphin A increases substance P release from trigeminal primary afferent C-fibers is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0014-2999(98)00897-8
P698PubMed publication ID10064148

P50authorHeberto Suarez-RocaQ44028969
P2093author name stringG Gómez
W Maixner
G Cano
J L Arcaya
P2860cites workThe anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonistQ24629716
Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific ActivityQ29618557
Immunohistochemical analysis of peptide pathways possibly related to pain and analgesia: enkephalin and substance P.Q35039144
Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal hornQ35702669
Capsazepine, a novel capsaicin antagonist, selectively antagonises the effects of capsaicin in the mouse spinal cord in vitroQ39244475
Interaction of beta-funaltrexamine with [3H]cycloFOXY binding in rat brain: further evidence that beta-FNA alkylates the opioid receptor complexQ41130393
Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brainQ41200323
Effects of selective and non-selective kappa-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neuronesQ41962723
Morphine produces a multiphasic effect on the release of substance P from rat trigeminal nucleus slices by activating different opioid receptor subtypesQ44332873
The mechanism of action for the block of NMDA receptor channels by the opioid peptide dynorphinQ44333039
Up-regulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammationQ44335339
Kappa 2 opioid receptors inhibit NMDA receptor-mediated synaptic currents in guinea pig CA3 pyramidal cells.Q44336683
Dynorphin prolongs the action potential of mouse sensory ganglion neurons by decreasing a potassium conductance whereas another specific kappa opioid does so by increasing a calcium conductanceQ44336820
Multiple opioid peptides and the modulation of pain: immunohistochemical analysis of dynorphin and enkephalin in the trigeminal nucleus caudalis and spinal cord of the cat.Q44345405
Opioid peptide immunoreactivity in spinal and trigeminal dorsal horn neurons projecting to the parabrachial nucleus in the rat.Q44346813
Spinal dynorphin A (1-17): possible mediator of antianalgesic actionQ44797694
Spinal release of immunoreactive dynorphin A(1-8) with the development of peripheral inflammation in the rat.Q49111477
Biochemical and anatomical observations on the degeneration of peptide-containing primary afferent neurons after neonatal capsaicinQ58493721
Differential effects of capsaicin on the content of somatostatin, substance P, and neurotensin in the nervous system of the ratQ63608758
Demonstration of dynorphin A 1-8 immunoreactive axons contacting spinal cord projection neurons in a rat model of peripheral inflammation and hyperalgesiaQ67525657
Phencyclidine and sigma receptors in rat spinal cord: binding characterization and quantitative autoradiographyQ69355388
A direct non-opiate interaction of dynorphin-(1-13) with the N-methyl-D-aspartate (NMDA) receptorQ69378113
Effects of traumatic injury on dynorphin immunoreactivity in spinal cordQ69863504
Intrathecally administered dynorphin-(1-17) modulates morphine-induced antinociception differently in morphine-naive and morphine-tolerant ratsQ69899455
Demonstration of calcitonin gene-related peptide immunoreactive axons contacting dynorphin A(1-8) immunoreactive spinal neurons in a rat model of peripheral inflammation and hyperalgesiaQ69929250
Distribution of chemosensitive primary sensory afferents in the central nervous system of the ratQ71269827
Sequential expression of c-fos protooncogene, TNF-alpha, and dynorphin genes in spinal cord following experimental traumatic injuryQ72124402
Dose-dependent effects of capsaicin on primary sensory neurons in the neonatal ratQ72687335
Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxoneQ73275114
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectdynorphinQ324076
substance PQ411041
P304page(s)27-34
P577publication date1999-01-01
P1433published inEuropean Journal of PharmacologyQ1376712
P1476titleDynorphin A increases substance P release from trigeminal primary afferent C-fibers
P478volume366

Reverse relations

cites work (P2860)
Q32062786A biochemical model of peripheral tinnitus
Q30491472Bi-phasic intensity-dependent opioid-mediated neural amplitude changes in the chinchilla cochlea: partial blockade by an N-Methyl-D-Aspartate (NMDA)-receptor antagonist
Q82028755Chapter 14 Descending excitatory systems
Q24631654Complications of long-term opioid therapy for management of chronic pain: the paradox of opioid-induced hyperalgesia
Q34659433Descending control of pain
Q44333127Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance.
Q34126256Endogenous opiates: 1999.
Q44580807Enhanced evoked excitatory transmitter release in experimental neuropathy requires descending facilitation.
Q44209091Expression of calcitonin gene-related peptide, substance P and protein kinase C in cultured dorsal root ganglion neurons following chronic exposure to mu, delta and kappa opiates
Q39391785Hyperalgesia: an emerging iatrogenic syndrome
Q35152165Induction of pain facilitation by sustained opioid exposure: relationship to opioid antinociceptive tolerance
Q34152988Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism
Q28252169Mechanism of allodynia evoked by intrathecal morphine-3-glucuronide in mice
Q37553194Nociceptive behavior induced by the endogenous opioid peptides dynorphins in uninjured mice: evidence with intrathecal N-ethylmaleimide inhibiting dynorphin degradation
Q44762691Nonopioid actions of intrathecal dynorphin evoke spinal excitatory amino acid and prostaglandin E2 release mediated by cyclooxygenase-1 and -2.
Q33695747Novel strategies for pharmacotherapy of depression
Q30752212Qualitative light and electron microscope study of glutamate receptors in the caudal spinal trigeminal nucleus of the rat.
Q42524394Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers.
Q46572332Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors
Q44037083Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain.

Search more.